Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations
Parisa Sabbagh,Mousa Mohammadnia-Afrouzi,Mostafa Javanian,Arefeh Babazadeh,Veerendra Koppolu,Veneela Krishna Rekha Vasigala,Hamid Reza Nouri,Soheil Ebrahimpour +7 more
TL;DR: Among non-invasive tests, urea breath test and fecal antigen tests are a quick diagnostic procedure with comparable accuracy to biopsy-based techniques and are methods of choice in the test and treatment setting.
read more
Abstract: Helicobacter pylori (H. pylori) resides in the stomach, colonizes gastric epithelium, and causes several digestive system diseases. Several diagnostic methods utilizing invasive or non-invasive techniques with varying levels of sensitivity and specificity are developed to detect H. pylori infection. Selection of one or more diagnostic tests will depend on the clinical conditions, the experience of the clinician, cost, sensitivity, and specificity. Invasive methods require endoscopy with biopsies of gastric tissues for the histology, culture, and rapid urease test. Among non-invasive tests, urea breath test and fecal antigen tests are a quick diagnostic procedure with comparable accuracy to biopsy-based techniques and are methods of choice in the test and treatment setting. Other techniques such as serological methods to detect immunoglobulin G antibodies to H. pylori can show high accuracy as other non-invasive and invasive biopsies, but do not differentiate between current or past H. pylori infections. Polymerase chain reaction (PCR) is an emerging option that can be categorized as invasive and non-invasive tests. PCR method is beneficial to detect H. pylori from gastric biopsies without the need for the cultures. There is no other chronic gastrointestinal infection such as H. pylori with a set of comparable diagnostic methodologies. Despite the availability of multiple diagnostic methods, it remains unclear on the choice of any one method as the gold standard for detecting H. pylori infection, especially in epidemiological studies. In this work, we review the principal diagnostic methods used to detect H. pylori infection and their advantages and disadvantages, and applications in clinical practice.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Modern Knowledge on Pathogenesis, Diagnosis and Treatment of Helicobacter Infection
H. Yu. Kiselev,C. L. Gorlenko,Ya. A. El-Taravi,E. E. Porubayeva,E. V. Budanova +4 more
TL;DR: This review summarizes modern knowledge on Helicobacter pylori pathogenesis, diagnosis, and treatment, highlighting the importance of accurate methods and effective eradication strategies due to increasing drug resistance and its link to various diseases, including gastrocarcinoma.
Invasive and non-invasive Helicobacter pylori diagnostic methods in Iran
Samin Alihosseini,Mehran Jaberinezhad,Fatemah SadeghpourHeravi,Reza Ghotaslou,Hamed Ebrahimzadeh Leylabadlo +4 more
TL;DR: Using a combination of non-invasive and invasive methods of H. pylori diagnosis, such as stool antigen test for screening and histopathology examination for precise diagnosis is the best option for treatment initiation.
Histopathological Features of Helicobacter pylori Infection in Gastric Mucosa
01 Nov 2022
TL;DR: In this paper , the authors investigated the histopathological characteristics of Helicobacter pylori (Hp) infection in the gastric mucosa in the process from occurrence to intraepithelial neoplasia.
Feco-prevalence, endoscopic pattern and associated factors of Helicobacter Pylori infection among symptomatic adult patients in Northern Tanzania
Ibrahim Ali Ibrahim Muhina,Abid M. Sadiq,Fuad H Said,Faryal M Raza,Sahir Gharib,Sophia S. Muhali,Andrea R Costantine,Maisa Abdalla,Laura J Shirima,Nyasatu Chamba,Furaha Lyamuya,Elifuraha Mkwizu,Kajiru Kilonzo,Venance P. Maro,Elichilia R. Shao +14 more
TL;DR: The H. pylori stool antigen can be used as the initial workup for symptomatic patients before the initiation of proton pump inhibitors and esophagogastroduodenoscopy be considered in the absence of other alarm symptoms if symptoms persist despite an appropriate trial of medical therapy.
References
Helicobacter pylori infection.
TL;DR: This review considers current knowledge about the epidemiology and transmission of H. pylori, as well as the role of this infectious agent in the pathogenesis of upper gastrointestinal tract disease.
3K
Pathogenesis of Helicobacter pylori Infection
TL;DR: This review focuses on the microbiological, clinical, immunological, and biochemical aspects of the pathogenesis of H. pylori, which represents a key factor in the etiology of various gastrointestinal diseases.
2.5K
Current concepts in the management of Helicobacter pylori infection - The Maastricht III Consensus Report
Peter Malfertheiner,Francis Mégraud,Colm O'Morain,Franco Bazzoli,Emad M. El-Omar,David Y. Graham,Richard H. Hunt,Theodore Rokkas,Nimish Vakil,Ernst J. Kuipers +9 more
TL;DR: H pylori eradication is less effective than proton pump inhibitor (PPI) treatment in preventing ulcer recurrence in long term NSAID users and a test and treat strategy using a non-invasive test is recommended in adult patients with persistent dyspepsia under the age of 45.
2.4K
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Peter Malfertheiner,Francis Mégraud,John Atherton,Anthony T. R. Axon,Franco Bazzoli,Gian Franco Gensini,Javier P. Gisbert,David Y. Graham,Ernst J. Kuipers +8 more
TL;DR: In this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010, with recommendations to guide doctors involved in the management of this infection associated with various clinical conditions.
Peptic ulcer disease
TL;DR: This work focuses on this revolution of understanding and management of peptic ulcer disease over the past 25 years, largely because of the increasingly widespread use of non-steroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin.
1.4K